LEERINK CENTER FOR PHARMACOECONOMICS

Serial Number 98876472
641

Registration Progress

Application Filed
Nov 27, 2024
Under Examination
Approved for Publication
Published for Opposition
Registered

Basic Information

Serial Number
98876472
Deadline
August 28, 2025
Description
Respond to Non-Final Office Action
Filing Date
November 27, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
641
Status Date
May 28, 2025
Application
Pending
Classes
009 035 036 041

Rights Holder

Leerink Intermediate Holdings LLC

16
Address
53 State Street
Boston, MA 02109

Ownership History

Leerink Intermediate Holdings LLC

Original Applicant
16
Boston, MA

Legal Representation

Attorney
Cynthia J. Walden
USPTO Deadlines 2 active
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
OFFICE ACTION
Non-Final Action Mailed
CNRT Aug 28, 2025 52 days Critical Until Nov 28, 2025
OFFICE ACTION
Non-Final Action E-Mailed
GNRT Aug 28, 2025 52 days Critical Until Nov 28, 2025
Next deadline: Non-Final Action Mailed on August 28, 2025 (52 days)

Application History

7 events
Date Code Type Description
May 28, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 28, 2025 GNRT F NON-FINAL ACTION E-MAILED
May 28, 2025 CNRT R NON-FINAL ACTION WRITTEN
May 20, 2025 DOCK D ASSIGNED TO EXAMINER
May 15, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 15, 2025 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 27, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 009
Downloadable reports, newsletters and educational materials related to financial matters and business consulting in the biotechnology, pharmaceutical, and health fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology; Downloadable software related to business information, financial information, and consulting for the same; Downloadable computer software and downloadable mobile applications for use in investment banking and management, accessing and conducting banking and financial business, and obtaining information, research, analysis, and advice in the fields of investments, banking, and financial services
Class 035
Business consulting; Business advisory; Acquisition and merger consultation; Providing trade information; Compiling financial, securities, stock exchange, trade and quote, index value and other financial market information for business purposes; Business intermediary services relating to the matching of potential investors with corporations and entrepreneurs needing funding; Business consultation services, namely, business evaluation regarding firms in the biotechnology, pharmaceutical, and health fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology
Class 036
Financial services, namely consulting and advising related to financial matters and business consulting in the biotechnology, pharmaceutical, and health fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology; Providing information related to financial matters and business consulting in the biotechnology, pharmaceutical, and health fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology; Financial consulting; Investment advisory and consulting services; Financial services, namely, investment advice, investment management, investment consultation; Information, advisory, consultancy and financial research services relating to finance and investments
Class 041
Online non-downloadable content related to financial matters and business consulting in the biotechnology, pharmaceutical, and health fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology; Providing a website featuring non-downloadable instructional videos, webinars and podcasts related to financial matters and business consulting in the biotechnology, pharmaceutical, and health fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology; Providing a website featuring non-downloadable instructional videos, webinars and podcasts in the field of finance; Arranging and conducting conferences and events in the field of finance

Additional Information

Design Mark
The mark consists of the word "LEERINK" to the left of a design element consisting of a vertical rectangular block to the left of a smaller vertical rectangular block above a horizontal rectangular block, with all of the foregoing above the words "CENTER FOR PHARMACOECONOMICS"
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
009 035 036 041